Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-α-producing cells

Journal of Autoimmunity

Volumn 11, Issue 5, 1998, Pages 465-470

  Cederblad, B ^b   Blomberg, S ^a   Vallin, H ^b   Perers, A ^b   Alm, G V ^b   Rönnblom, Lars ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

Dendritic cells; Herpes simplex virus; Interferon ; Sendai virus; Systemic lupus erythematosus

Indexed keywords

ALPHA INTERFERON; AZATHIOPRINE; PREDNISOLONE; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; AGED; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOSTIMULATION; MALE; MONONUCLEAR CELL; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; SENDAI VIRUS; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0032191321     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1998.0215     Document Type: Conference Paper

References (40)

1. 1. Wallace D.J., Hahn B.H. 1997. Dubois' Lupus Erythematosus. 5th Edn. Williams & Wilkins, Baltimore
2. 2. Ytterberg S.R., Schnitzer T.J. 1982. Serum interferon levels in patients with systemic lupus erythematosus. Arthritis Rheum. 25: 401-406
3. 3. von Wussow P., Jakschies D., Hochkeppel H., Horisberger M., Hartung K., Deicher H. 1989. MX homologous protein in mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum. 32: 914-918
4. 4. von Wussow P., Jakschies D., Hartung K., Deicher H. 1988. Presence of interferon and anti-interferon in patients with systemic lupus erythematosus. Rheumatol. Int. 8: 225-230
5. 5. Matei I., Ghyka G., Savi I., Tudor A. 1990. Correlation of serum interferon with some clinical and humoral signs of systemic lupus erythematosus. Med. Interne 28: 289-294
6. 6. Shou-Nee S., Fang F.S., Yumei W., Fang H.L., Xing H.Y. 1987. Serum interferon in systemic lupus erythematosus. Brit. J. Dermatol. 117: 155-159
7. 7. Fritzler M.J. 1994. Drugs recently associated with lupus syndromes. Lupus 3: 455-459
8. 8. Rönnblom L.E., Alm G.V., Öberg K.E. 1991. Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann. Int. Med. 115: 178-183
9. 9. Rönnblom L.E., Alm G.V., Öberg K.E. 1990. Possible induction of systemic lupus erythematosus by interferon-α treatment in a patient with a malignant carcinoid tumour. J. Int. Med. 227: 207-210
10. 10. Belardelli F. 1995. Role of interferons and other cytokines in the regulation of the immune response. APMIS 103: 161-179
11. 11. Belardelli F., Gresser I. 1996. The neglected role of type I interferon in the T-cell response: implications for its clinical use. Immunol. Today 17: 369-371
12. 12. Salazar Mather T.P., Ishikawa R., Biron C.A. 1996. NK cell trafficking and cytokine expression in splenic compartments after IFN induction and viral infection. J. Immunol. 157: 3054-3064
13. 13. Riffault S., Eloranta M.-L., Carrat C., Sandberg K., Charley B., Alm G. 1996. Herpes simplex virus induced appearance of IFN-α/β producing cells and partially IFN-α/β dependent accumulation of leukocytes in murine regional lymph nodes. J. Interferon Res. 16: 1007-1014
14. 14. Rogge L., Barberis-Maino L., Biffi M., Passini N., Presky D.H., Gubler U., Sinigaglia F. 1997. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 5: 825-831
15. 15. D'Cunha J., Ramanujam S., Wagner R.J., Witt P.L., Knight Jr E., Borden E.C. 1996. In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine. J. Immunol. 157: 4100-4108
16. 16. Gray D. 1996. Viral immunity: interferons jog old T-cell memories. Curr. Biol. 6: 1254-1255
17. 17. Fitzgerald-Bocarsly P 1993. Human natural interferon-α producing cells. Pharmac. Ther. 60: 39-62
18. 18. Svensson H., Cederblad B., Lindahl M., Alm G.V. 1996. Stimulation of natural interferon-α/β-producing cells by Staphylococcus aureus. J. Interferon Res. 16: 7-16
19. 19. Svensson H., Johannisson A., Nikkilä T., Alm G.V., Cederblad B. 1996. The cell surface phenotype of human natural interferon-α producing cells as determined by flow cytometry. Scand. J. Immunol. 44: 164-172
20. 20. Rönnblom L., Alm G.V. 1982. Limiting dilution analysis of human peripheral blood mononuclear leukocytes that react to human amnion cells and protect these against viral challenge. Eur J. Immunol. 12: 437-441
21. 21. Cederblad B., Alm G.V. 1990. Infrequent but efficient interferon-α producing human mononuclear leukocytes induced by herpes simplex virus in vitro studied by immuno-plaque and limiting dilution assays. J. Interferon Res. 10: 6573
22. 22. Feldman S.B., Ferraro M., Zheng H.-M., Patel N., Gould-Fogerite S., Fitzgerald-Bocarsly P. 1994. Viral induction of low frequency interferon-α producing cells. Virology 204: 65-73
23. 23. Alarcon Segovia D., Ruiz Gomez J., Fishbein E., Bustamante M.E. 1974. Interferon production by lymphocytes from patients with systemic lupus erythematosus. Arthritis Rheum. 17: 590-592
24. 24. Neighbour P.A., Grayzel I. 1981. Interferon production in vitro by leucocytes from patients with systemic lupus erythematosus and rheumatoid arthritis. Clin. Exp. Immunol. 45: 576-582
25. 25. Strannegård O., Hermodsson S., Westberg G. 1982. Interferon and natural killer cells in systemic lupus erythematosus. Clin. Exp. Immunol. 50: 246-252
26. 26. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., Schaller J.G., Talal N., Winchester R.J. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25: 1271-1277
27. 27. Cederblad B., Riesenfeld T., Alm G.V. 1990. Deficient herpes simplex virus-induced interferon-α production by blood leukocytes of preterm and term newborn infants. Pediatar. Res. 27: 7-10
28. 28. Artursson K., Lindersson M., Varela N., Scheynius A., Alm G.V. 1995. Interferon-α production and tissue localization of interferon-α/β producing cells after intradermal administration of Aujeszky's disease virus-infected cells in pigs. Scand. J. Immunol. 41: 121-129
29. 8 units/ml. J. Gen Virol. 39: 541-543
30. 30. Rönnblom L.E., Tiensuu Jansson E., Perers A., Öberg K.E., Alm G.V. 1992. Characterization of anti-interferon-α antibodies appearing during recombinant interferon-α2a treatment. Clin. Exp. Immunol. 89: 330-335
31. 31. Cederblad B., Alm G.V. 1991. Interferons and the colony-stimulating factors IL-3 and GM-CSF enhance the IFN-alpha response in human blood leucocytes induced by herpes simplex virus. Scand. J. Immunol. 34: 549-555
32. 32. Lebon P. 1985. Inhibition of herpes simplex virus type 1-induced interferon synthesis by monoclonal antibodies against viral glycoprotein D and by lysosomotropic drugs. J. Gen. Virol. 66: 2781-2786
33. 33. Neighbour P.A., Grayzel A.I. 1981. Interferon production in vitro by leucocytes from patients with systemic lupus erythematosus and rheumatoid arthritis. Clin. Exp. Immunol. 45: 576-582
34. 34. Wong G.H., Goeddel D.V. 1986. Tumor necrosis factor α and α inhibit replication and synergize with interferons. Nature 323: 819-822
35. 35. Improta T., Pine R., Pfeffer L.M. 1992. Interferon-γ potentiates the anti-viral activity and the expression of interferon-stimulated genes induced by interferon-α in U937. J. Interferon Res. 12: 87-94
36. 36. Payvandi F., Fitzgerald-Bocarsly P. 1995. IL-10 inhibits production of IFN-α by PBMC induced with herpes simplex virus or sendai virus. J. Interferon Res. 15: S165
37. 37. Llorente L., Richaud-Patin Y., Wijdenes J., Alcocer-Varela J., Maillot M., Duran-Gasselin I., Fourrier B., Galanaud P., Emilie D. 1993. Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus. Eur. Cytokine Net. 4: 421-430
38. 38. Hagiwara E., Gourley M.F., Lee S., Klinman D.M. 1996. Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10:interferon-γ secreting cells in the peripheral blood. Arthritis Rheum. 39: 379-385
39. 39. Eloranta M.-L., Sandberg K., Alm G.V. 1996. The interferon-α/β responses of mice to herpes simplex virus studied at the blood and tissue level in vitro and in vivo. Scand. J. Immunol. 43: 355-360
40. 40. Tsokos G.C., Kovacs B., Sfikakis P.P., Theocharis S., Vogelgesang S., Via C.S. 1996. Defective antigen-presenting cell function in patients with systemic lupus erythematosus. Arthritis Rheum. 39: 600-609